The growth and metastasis of HCC cells are inhibited by protecting TIMP metallopeptidase inhibitor 3 (TIMP3) from the downregulation of miR-17-3p and miR-181b-5p. This evidence concerns the gene TIMP3 and hepatocellular carcinoma.